DCDouglas A. Colquhoun

Douglas A. Colquhoun

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Douglas A. Colquhoun has a total of 149 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Effect of In-line Clinical Decision Support to Improve Accuracy of American Society of Anesthesiologists Physical Status Documentation: A Two-center Evaluation of a Quality Intervention

    by Zachary R. Murphy, Douglas A. Colquhoun, Graciela B. Mentz, Michael L. Burns, Michael R. Mathis, York Jiao, Nirav J. Shah, Matthew C. Wixson, Bishr Haydar, Thomas T. Klumpner

    Background: American Society of Anesthesiologists (ASA; Schaumburg, Illinois) Physical Status (PS) classification is a widely used ordinal scale that captures comorbidity burden but has significant interrater variability. Previous efforts to enhance ASA PS documentation with clinical decision support are limited by inaccurate problem lists, poor user experience, or consideration of select comorbidities. The authors developed and implemented clinical decision support which uses the anesthesia clinicians’ documentation to highlight potential underclassification at time of ASA PS assignment. Methods: Building upon examples from the ASA Committee on Economics and institutional consensus, the authors identified 51 conditions warranting an ASA PS of at least III. This was embedded in clinical decision support and implemented at the authors’ large academic medical center (site 1). The authors compared the percentage of patients assigned an ASA PS III or greater before (May 22, 2023, to May 22, 2024) and after complete implementation (August 14, 2024, to August 14, 2025). A second large midwestern academic medical center served as a contemporaneous external control (site 2). Using a difference in difference analysis, the authors constructed odds ratios for assignment of ASA PS III in all patients and selected subpopulations. Results: The study included 251,944 anesthetics from site 1 and 286,172 from site 2. Baseline characteristics were similar between sites. At site 1, the proportion of patients classified as ASA PS III or higher increased from 52.9 to 61.7% (adjusted odds ratio [aOR], 1.42; 95% CI, 1.38 to 1.45). Site 2 experienced a small absolute increase from 47.2 to 48.4% (aOR, 1.05; 95% CI, 1.03 to 1.07). Among patients at site 1 with 50 conditions addressed by the latter phase of the clinical decision support, the proportion classified as ASA PS III or greater increased from 83.6 to 94.0% (aOR, 3.54; 95% CI, 3.34 to 3.76). Conclusions: Implementation of the authors’ in-line real-time clinical decision support was associated with a significant increase in the percentage of patients with ASA PS III or greater.

  • Open Access

    Disparities in Antiemetic Prophylaxis Care Processes Predicted by Patient Neighborhood: Retrospective Cohort and Geospatial Analysis

    by Jiuying Han, Neng Wan, Cameron K Jacobson, Nathan L Pace, Cade K Kartchner, Alexander Hohl, Robert B Schonberger, Douglas A Colquhoun, Richard P Dutton, Michael Andreae, et al.

    Background: Social determinants of health continue to drive persistent disparities in perioperative care. Our team has previously demonstrated racial and socioeconomic disparities in perioperative processes, notably in the administration of antiemetic prophylaxis, in several large perioperative registries. Given how neighborhoods are socially segregated in the United States, we examined geospatial clustering of perioperative antiemetic disparities. Objective: The study aimed to determine whether disparities in perioperative antiemetic prophylaxis exhibit geographic clustering based on neighborhood-level disadvantage and whether patients from disadvantaged communities are more likely to be undertreated after adjusting for individual postoperative nausea and vomiting risk. Methods: We conducted a retrospective cohort study of anesthetic records from the University of Utah Hospital involving 19,477 patients who met the inclusion criteria. We geocoded patient home addresses and combined them with the census block group–level neighborhood disadvantage, a composite index from the National Neighborhood Data Archive. We stratified our patients by antiemetic risk score and calculated the number of antiemetic interventions. We used Poisson spatial scan statistics, implemented in SaTScan (Information Management Services, Inc), to detect geographic clusters of undertreatment. Results: We identified 1 significant cluster ( P <.001) of undertreated perioperative antiemetic prophylaxis cases. The relative risk of the whole cluster was 1.44, implying that patients within the cluster were 1.44 times more likely to receive fewer antiemetics after controlling for antiemetic risk. Patients from more disadvantaged neighborhoods were more likely to receive below-median antiemetic prophylaxis after controlling for risk. Conclusions: To our knowledge, this is the first geospatial cluster analysis of perioperative process disparities; we leveraged innovative geostatistical methods and identified a spatially defined, geographic cluster of patients whose home address census-tract level neighborhood deprivation index predicted disparities in risk-adjusted antiemetic prophylaxis.

  • Open Access

    Trajectories of Recovery after Intravenous propofol versus inhaled VolatilE anaesthesia (THRIVE) randomised controlled trial in the USA: A protocol

    by Bethany R Tellor Pennington, Allison M Janda, Douglas A Colquhoun, Mark D Neuman, Kelley M Kidwell, Cathie Spino, Steven Thelen-Perry, Amy Krambrink, Suiyuan Huang, Rose Ignacio, et al.

    Introduction Millions of patients receive general anaesthesia every year with either propofol total intravenous anaesthesia (TIVA) or inhaled volatile anaesthesia (INVA). It is currently unknown which of these techniques is superior in relation to patient experience, safety and clinical outcomes. The primary aims of this trial are to determine (1) whether patients undergoing (a) major inpatient surgery, (b) minor inpatient surgery or (c) outpatient surgery have a superior quality of recovery after INVA or TIVA and (2) whether TIVA confers no more than a small (0.2%) increased risk of definite intraoperative awareness than INVA. Methods and analysis This protocol was co-created by a diverse team, including patient partners with personal experience of TIVA or INVA. The design is a 13 000-patient, multicentre, patient-blinded, randomised, comparative effectiveness trial. Patients 18 years of age or older, undergoing elective non-cardiac surgery requiring general anaesthesia with a tracheal tube or laryngeal mask airway will be eligible. Patients will be randomised 1:1 to one of two anaesthetic approaches, TIVA or INVA, using minimisation. The primary effectiveness endpoints are Quality of Recovery-15 (QOR-15) score on postoperative day (POD) 1 in patients undergoing (1) major inpatient surgery, (2) minor inpatient surgery or (3) outpatient surgery, and the primary safety endpoint is the incidence of unintended definite intraoperative awareness with recall in all patients, assessed on POD1 or POD30. Secondary endpoints include QOR-15 score on POD0, POD2 and POD7; incidence of delirium on POD0 and POD1; functional status on POD30 and POD90; health-related quality of life on POD30, POD90, POD180 and POD365; days alive and at home at POD30; patient satisfaction with anaesthesia at POD2; respiratory failure on POD0; kidney injury on POD7; all-cause mortality at POD30 and POD90; intraoperative hypotension; moderate-to-severe intraoperative movement; unplanned hospital admission after outpatient surgery in a free-standing ambulatory surgery centre setting; propofol-related infusion syndrome and malignant hyperthermia. Ethics and dissemination This study is approved by the ethics board at Washington University, serving as the single Institutional Review Board for all participating sites. Recruitment began in September 2023. Dissemination plans include presentations at scientific conferences, scientific publications, internet-based educational materials and mass media. Trial registration number NCT05991453.


  • Patient Blood Management: Moving Beyond Guidelines to Action

    by Douglas A. M.B. Colquhoun, Gabor M.D. Erdoes


  • Open Access

    Clinical and Genetic Factors Associated with Intraoperative Minimum Alveolar Concentration Ratio: A Single-center Retrospective Cohort and Genome-wide Association Study

    by Nicholas J. Douville, Elizabeth S. Jewell, Xinyi Zhao, Douglas A. MB ChB Colquhoun, Emily Bertucci-Richter, Sebastian Zöllner, Ryan P. Davis, Sathish S. Kumar, George A. Mashour

    Background: Minimum alveolar concentration (MAC) is a standard dosing metric for general anesthesia. Although influences of MAC have been identified in controlled studies, the determinants of clinical delivery of MAC ratio are largely unknown. To address this knowledge gap, the authors performed this single-center retrospective study. The primary objective was to understand factors associated with MAC ratio, as indexed by the end-tidal volatile anesthetic concentration, for a given case. It was hypothesized that mean arterial pressure (MAP) was strongly associated with anesthetic delivery; a secondary objective was to perform a genome-wide association study to identify genetic variants associated with MAC ratio in clinical practice. Methods: The primary outcome was mean age-adjusted MAC ratio during the maintenance phase of anesthesia. The primary exposure variable was mean MAP during the same time window. The correlation between the outcome, exposure, and a variety of demographic, laboratory, procedural, and anesthetic covariates was assessed in adjusted multivariable linear regressions. Next, the authors performed two genome-wide association studies of clinically delivered MAC ratio. Results: Of the 30,125 cases included in the final dataset, mean ± SD age-adjusted MAC ratio was 1.066 ± 0.173, and mean MAP was 82 ± 10 mmHg. MAP was associated with MAC ratio in the overall model (β = 0.0028; 95% CI, 0.0024 to 0.0032; P < 0.0001). A variety of demographic ( e.g. , female sex: β = –0.0182; 95% CI, –0.0219 to –0.0144; P < 0.0001), laboratory, surgical, and anesthetic factors were also associated with anesthetic agent concentration. Eight variants located near six genes ( DPH6 , CPM , EEFSEC , SGSM1 , CDH9 , and DISC1 ) reached the lower suggestive threshold ( P < 1 × 10 -6 ) in one but not both models; none exceed the threshold for genome-wide significance ( P < 5 × 10 -8 ). Conclusions: The hypothesis was verified that MAP was associated with clinical delivery of MAC ratio. The authors also characterized practice patterns of inhalational anesthetic management and identified numerous covariates that need to be accounted for when modeling anesthetic requirements. Female patients received lower doses of anesthetic, despite evidence that they have a higher requirement. While genome-wide association studies failed to identify novel variants at the level of genome-wide significance ( P < 5 × 10 -8 ), multiple mechanistically plausible genes were suggested. Notably, the DISC1 gene has been shown to impact resting-state brain activations under general anesthesia with isoflurane and has been linked to abnormal sleep/wake patterns.


  • Accounting for Healthcare Structures When Measuring Variation in Care

    by Douglas A. M.B.Ch.B. Colquhoun, Allison M. Janda, Graciela Mentz, Clark A. M.D. Fisher, Robert B. M.D. Schonberger, Nirav Shah, Sachin M.D. Kheterpal, Michael R. Mathis

    Health services research frequently focuses on variation in the structure, process, and outcomes of clinical care. Robust approaches for detection and attribution of variation are foundational to both quality improvement and outcomes research. Describing care in structured healthcare systems across hospitals in which clinicians work to provide care for patients as a multileveled structure allows the impact of organization on practice and outcome to be ascertained. Mixed-effect statistical models can describe both the partitioning of variation among levels of these structures and by inclusion of explanatory variables the valid estimation of the features of health systems, clinicians, or patients, with observed differences in processes or patient outcomes. In this Readers’ Toolbox, the authors describe the rationale for considering healthcare structures when assessing clinical practice, outcomes, and sources of variation. They describe statistical considerations and methods for the estimation of analysis of structured data and assessment of variance.


  • Open Access

    Environmental and patient safety outcomes of a health-system Green Anesthesia Initiative (GAIA): a retrospective observational cohort study

    by Douglas A Colquhoun, David Hovord, Robyn Rachel, Yuan Yuan, Graciela B Mentz, Prabhat Koppera, Timur Z Dubovoy, Paul Picton, George A Mashour